| [1] |
Li X, Liu Z, Wang L, et al. Tacrolimus monotherapy after intravenous methylprednisolone in adults with minimal change nephrotic syndrome [J]. J Am Soc Nephrol, 2017, 28(4): 1286-1295.
|
| [2] |
Kampf LL, Schneider R, Gerstner L, et al. TBC1D8B mutations implicate RAB11-dependent vesicular trafficking in the pathogenesis of nephrotic syndrome [J]. J Am Soc Nephrol, 2019, 30(12): 2338-2353.
|
| [3] |
Fang Z, Zhang C, Jin Y, et al. Adult-onset focal segmental glomerulosclerosis with steroid-dependent nephrotic syndrome caused by a novel TBC1D8B variant: a case report and literature review [J]. Am J Kidney Dis, 2023, 81(2): 240-244.
|
| [4] |
Xu Y, Dai C, He J, et al. Novel TBC1D8B variant causes neonatal nephrotic syndrome combined with acute kidney injury [J]. Ital J Pediatr, 2024, 50(1): 222.
|
| [5] |
Hu X, Cheng W, Xu X, et al. Adult-onset female focal segmental glomerulosclerosis with nephrotic syndrome caused by a TBC1D8B variant: a case report [J]. Clin Kidney J, 2024, 17(12): sfae310.
|
| [6] |
Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the clinical genome resource (ClinGen) [J]. Genet Med, 2020, 22(2): 245-257.
|
| [7] |
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases [J]. Kidney Int, 2021, 100(4S): S1-S276.
|
| [8] |
Pollak MR. The genetic basis of FSGS and steroid-resistant nephrosis [J]. Semin Nephrol, 2003, 23(2): 141-146.
|
| [9] |
Dorval G, Kuzmuk V, Gribouval O, et al. TBC1D8B loss-of-function mutations lead to X-linked nephrotic syndrome via defective trafficking pathways [J]. Am J Hum Genet, 2019, 104(2): 348-355.
|
| [10] |
Hou L, Yin L, Wu Y, et al. Novel TBC1D8B variant in a 6-month-old boy with steroid-sensitive nephrotic syndrome: a case report [J]. Front Pediatr, 2021, 9: 732512.
|
| [11] |
Lyon MF. Gene action in the X-chromosome of the mouse (Mus musculus L．) [J]. Nature, 1961, 190: 372-373.
|
| [12] |
Gono T, Yazaki M, Agematsu K, et al. Adult onset X-linked chronic granulomatous disease in a woman patient caused by a de novo mutation in paternal-origin CYBB gene and skewed inactivation of normal maternal X chromosome [J]. Intern Med, 2008, 47(11): 1053-1056.
|
| [13] |
Kobayashi N, Fujisawa H, Kumagai J, et al. New-onset minimal change disease following the moderna COVID-19 vaccine [J]. BMJ Case Rep, 2023, 16(9): e255144.
|
| [14] |
Lebedev L, Sapojnikov M, Wechsler A, et al. Minimal change disease following the Pfizer-BioNTech COVID-19 vaccine [J]. Am J Kidney Dis, 2021, 78(1): 142-145.
|
| [15] |
Kobayashi S, Fugo K, Yamazaki K, et al. Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination [J]. Clin Kidney J, 2021, 14(12): 2606-2607.
|
| [16] |
Thappy S, Thalappil SR, Abbarh S, et al. Minimal change disease following the Moderna COVID-19 vaccine: first case report [J]. BMC Nephrol, 2021, 22(1): 376.
|
| [17] |
Hartley JL, Bailey N, Sharma A, et al. Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases [J]. BMJ Case Rep, 2022, 15(3): e244638.
|
| [18] |
Phelan PJ, Hall G, Wigfall D, et al. Variability in phenotype induced by the podocin variant R229Q plus a single pathogenic mutation [J]. Clin Kidney J, 2015, 8(5): 538-542.
|
| [19] |
Ardiles LG, Carrasco AE, Carpio JD, et al. Late onset of familial nephrotic syndrome associated with a compound heterozygous mutation of the podocin-encoding gene [J]. Nephrology (Carlton), 2005, 10(6): 553-556.
|
| [20] |
Qi XM, Wang J, Xu XX, et al. FK506 reduces albuminuria through improving podocyte nephrin and podocin expression in diabetic rats [J]. Inflamm Res, 2016, 65(2): 103-114.
|
| [21] |
Ichinose K. The role of podocytes in lupus nephritis: insights and implications [J]. Clin Immunol, 2024, 262: 110180.
|
| [22] |
Engel P. B cell-associated surface molecules and B cell responses [M]. In: Ratcliffe MJH. Encyclopedia of immunobiology. Amsterdam: Elsevier, 2016: 253-258.
|
| [23] |
Taher TE, Bystrom J, Ong VH, et al. Intracellular B lymphocyte signalling and the regulation of humoral immunity and autoimmunity [J]. Clin Rev Allergy Immunol, 2017, 53(2): 237-264.
|
| [24] |
Kim AH, Chung JJ, Akilesh S, et al. B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement [J]. JCI Insight, 2017, 2(21): e81836.
|
| [25] |
Zhang H, Nair V, Saha J, et al. Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice [J]. Kidney Int, 2017, 92(4): 909-921.
|
| [26] |
Lin AA, Freeman AF, Nutman TB. IL-10 indirectly downregulates IL-4-induced IgE production by human B cells [J]. Immunohorizons, 2018, 2(11): 398-406.
|